Skip to main content
Log in

Phosphodiesterase 4 and compartmentalization of cyclic AMP signaling

  • Review
  • Published:
Chinese Science Bulletin

Abstract

Cyclic AMP (cAMP), as a second messenger, plays a critical role in cellular signaling transduction. However, it is not clear how this apparently identical cAMP signal induces divergent physiological responses. The potential explanation that cAMP signaling is compartmentalized was proposed by Buxton and Brunton twenty years ago. Compartmentalization of cAMP signaling allows spatially distinct pools of protein kinase A (PKA) to be differently activated. Research on cAMP signaling has regained impetus in many fields of life sciences due to the progress in understanding cAMP signaling complexity and functional diversity. The cAMP/PKA signaling compartments are maintained by A-kinase anchoring proteins (AKAPs) which bind PKA and other signaling proteins, and by PDEs which hydrolyse cAMP and thus terminate PKA activity. PDE4 enzymes belong to PDE superfamily and stand at a crossroad that allows them to integrate various signaling pathways with that of cAMP in spatially distinct compartments. In the current review, the nomenclature, taxonomy and gene expression of PDE4, and the system and region of its effect are described. In addition, the idiographic molecules, mechanisms, and regulation models of PDE4 are summarized. Furthermore, the important roles PDE4 plays in the maturation of rat granulosa cells and cAMP signaling compartmentalization are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Houslay M D, Schafer P, Zhang K Y. Keynote review: Phosphodiesterase-4 as a therapeutic target. Drug Discov Today, 2005, 10(22): 1503–1519

    Article  Google Scholar 

  2. Conti M, Richter W, Mehats C, et al. Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling. J Biol Chem, 2003, 278(8): 5493–5496

    Article  Google Scholar 

  3. Houslay M D, Milligan G. Tailoring cAMP signalling responses through isoform multiplicity. Trends Biochem Sci, 1997, 22: 217–224

    Article  Google Scholar 

  4. Beavo J A, Brunton L L. Cyclic nucleotide research-still expanding after half a century. Nat Rev Mol Cell Biol, 2002, 3: 710–718

    Article  Google Scholar 

  5. Evellin S, Mongillo M, Terrin A, et al. Measuring dynamic changes in cAMP using fluorescence resonance energy transfer. Methods Mol Biol, 2004, 284: 259–270

    Google Scholar 

  6. Houslay M D, Adams D R. PDE4 cAMP phosphodiesterases: Modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem J, 2003, 370(Pt 1): 1–18

    Article  Google Scholar 

  7. Henn V, Stefan E, Baillie G S, et al. Compartmentalized cAMP signalling regulates vasopressin-mediated water reabsorption by controlling aquaporin-2. Biochem Soc Trans, 2005, 33(Pt 6): 1316–1318

    Google Scholar 

  8. Huang T, McDonough C B, Abel T. Compartmentalized PKA signaling events are required for synaptic tagging and capture during hippocampal late-phase long-term potentiation. Eur J Cell Biol, 2006, 85: 635–642

    Article  Google Scholar 

  9. Alto N M, Scott J D. The role of A-kinase anchoring proteins in camp-mediated signal transduction pathways. Cell Biochem Biophys, 2004, 40(3 Suppl): 201–208

    Article  Google Scholar 

  10. Levine C G, Mitra D, Sharma A, et al. The efficiency of protein compartmentalization into the secretory pathway. Mol Biol Cell, 2005, 16(1): 279–291

    Article  Google Scholar 

  11. Wang Z, Huang R, Pan L, et al. Molecular structures, physiological roles and regulatory mechanisms of cyclic nucleotide-gated ion channels. Chin J Biochem Mol Biol (in Chinese), 2006, 22(4): 282–288

    Google Scholar 

  12. Dousa T P. Cyclic-3′,5′-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney. Kidney Int, 1999, 55(1): 29–62

    Article  Google Scholar 

  13. Matsumoto T, Kobayashi T, Kamata K. Phosphodiesterases in the vascular system. J Smooth Muscle Res, 2003, 39(4): 67–86

    Article  Google Scholar 

  14. Beard M B, Olsen A E, Jones R E, et al. UCR1 and UCR2 domains unique to the cAMP-specific phosphodiesterase family form a discrete module via electrostatic interactions. J Biol Chem, 2000, 275: 10349–10358

    Article  Google Scholar 

  15. Lugnier C. Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents. Pharmacol Therapeut, 2006, 109: 366–398

    Article  Google Scholar 

  16. Torphy T J. Phosphodiesterase isozymes: Molecular targets for novel antiasthma agents. Am J Respir Crit Care Med, 1998, 157(2): 351–370

    Google Scholar 

  17. Conti M, Jin S L. The molecular biology of cyclic nucleotide phosphodiesterases. Prog Nucleic Acid Res Mol Biol, 1999, 63: 1–38

    Article  Google Scholar 

  18. Conti M. Phosphodiesterases and cyclic nucleotide signaling in endocrine cells. Mol Endocrinol, 2000, 14(9): 1317–1327

    Article  Google Scholar 

  19. Mehats C, Andersen C B, Filopanti M, et al. Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling. Trends Endocrinol Metab, 2002, 13(1): 29–35

    Article  Google Scholar 

  20. Huston E, Houslay T M, Baillie G S, et al. cAMP phosphodiesterase-4A1 (PDE4A1) has provided the paradigm for the intracellular targeting of phosphodiesterases, a process that underpins compartmentalized cAMP signalling. Biochem Soc Trans, 2006, 34(Pt 4): 504–509

    Google Scholar 

  21. Jin S L, Bushnik T, Lan L, et al. Subcellular localization of rolipram-sensitive, cAMP-specific phosphodiesterases. Differential targeting and activation of the splicing variants derived from the PDE4D gene. J Biol Chem, 1998, 273(31): 19672–19678

    Article  Google Scholar 

  22. Perry S J, Baillie G, Kohout T A, et al. Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins. Science, 2002, 298: 834–836

    Article  Google Scholar 

  23. Baillie G S, Houslay M D. Arrestin times for compartmentalised cAMP signalling and phosphodiesterase-4 enzymes. Curr Opin Cell Biol, 2005, 17(2): 129–134

    Article  Google Scholar 

  24. Wong W, Scott J D. AKAP signalling complexes: Focal points in space and time. Nat Rev Mol Cell Biol, 2004, 5(12): 959–970

    Article  Google Scholar 

  25. Bolger G B, Baillie G S, Li X, et al. Scanning peptide array analyses identify overlapping binding sites for the signalling scaffold proteins, beta-arrestin and RACK1, in cAMP-specific phosphodiesterase PDE4D5. Biochem J. 2006, 398(1): 23–36

    Article  Google Scholar 

  26. Tasken K, Stokka A J. The molecular machinery for cAMP-dependent immunomodulation in T-cells. Biochem Soc Trans. 2006, 34(Pt 4): 476–479

    Google Scholar 

  27. Tasken K, Aandahl E M. Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol Rev, 2004, 84: 137–167

    Article  Google Scholar 

  28. Cooper D M. Compartmentalization of adenylate cyclase and cAMP signalling. Biochem Soc Trans, 2005, 33(Pt 6): 1319–1322

    Google Scholar 

  29. Houslay M D, Baillie G S. Phosphodiesterase-4 gates the ability of protein kinase A to phosphorylate G-protein receptor kinase-2 and influence its translocation. Biochem Soc Trans, 2006, 34(Pt 4): 474–475

    Google Scholar 

  30. Willoughby D, Wong W, Schaack J, et al. An anchored PKA and PDE4 complex regulates subplasmalemmal cAMP dynamics. EMBO J, 2006, 25(10): 2051–2061

    Article  Google Scholar 

  31. Ji J, Zhang X, Li B. β-adrenergic modulation of in vivo long-term potentiation in area CA1 and its role in spatial learning in rats. Sci China Ser C-Life Sci, 2003, 46(6): 605–614

    Article  Google Scholar 

  32. McConnachie G, Langeberg L K, Scott J D. AKAP singaling complexs: Getting to the heart of the matter. Trends in Mol Med, 2006, 12(7): 317–323

    Article  Google Scholar 

  33. Lim J, Pahlke G, Conti M. Activation of the cAMP-specific phosphodiesterase PDE4D3 by phosphorylation. Identification and function of an inhibitory domain. J Biol Chem, 1999, 274: 19677–19685

    Article  Google Scholar 

  34. Hoffmann R, Wilkinson IR, McCallum JF, et al. cAMP-specific phosphodiesterase HSPDE4D3 mutants which mimic activation and changes in rolipram inhibition triggered by protein kinase A phosphorylation of Ser-54: Generation of a molecular model. Biochem J, 1998, 333: 139–149

    Google Scholar 

  35. Busch C J, et al. Nitric oxide induces phosphodiesterasse 4B expression in rat pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2006, 290(4): L747–L753

    Article  Google Scholar 

  36. Tian Z X, Mao X J, Su W. Exogenous cAMP upregulates the expression of glnII and glnK-amtB genes in Sinorhizobium meliloti 1021. Chin Sci Bull, 2006, 51(16): 1982–1985

    Article  Google Scholar 

  37. Li P, Wang Z W, Yan J. Neuro-protective effects of CNTF on hippocampal neurons via an unknown signal transduction pathway. Chin Sci Bull, 2006, 51(1): 48–53

    Article  Google Scholar 

  38. Li Z, Sun Y, Mao X. cAMP receptor protein (CRP) downregulates Klebsiella pneumoniae nif promoters in Escherichia coli. Chin Sci Bull, 2002, 47(19): 1622–1628

    Article  Google Scholar 

  39. Oki N, Takahashi S I, Hidaka H, et al. Short term feedback regulation of cAMP in FRTL-5 thyroid cells. Role of PDE4D3 phosphodiesterase activation. J Biol Chem, 2000, 275: 10831–10837

    Article  Google Scholar 

  40. Jin S-L C, Richard F, Kuo W P, et al. Impaired growth and fertility of cAMP-specific phosphodiesterase PDE4D-deficient mice. Proc Natl Acad Sci USA, 1999, 96: 11998–12003

    Article  Google Scholar 

  41. Hansen G, Jin S-L C, Umetsu D, et al. Absence of muscarinic cholinergic airway responses in mice deficient in the cyclic nucleotide phosphodiesterase PDE4D. Proc Natl Acad Sci USA, 2000, 97: 6751–3756

    Article  Google Scholar 

  42. Hoffmann R., Baillie G S, MacKenzie S J, et al. The MAP kinase ERK2 inhibits the cAMP-specific phosphodiesterase, HSPDE4D3 by phosphorylating it at Ser579. EMBO J, 1999, 18: 893–903

    Article  Google Scholar 

  43. Houslay M D, Kolch W. Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling. Mol Pharmacol, 2000, 58: 659–668

    Google Scholar 

  44. Dodge-Kafka K L, Soughayer J, Pare G C, et al. The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature, 2005, 437: 574–578

    Article  Google Scholar 

  45. Park J Y, Richard F, Chun S Y, et al. Phosphodiesterase regulation is critical for the differentiation and pattern of gene expression in granulosa cells of the ovarian follicle. Mol Endocrinol, 2003, 17(6): 1117–1130

    Article  Google Scholar 

  46. Shi F, Perez E, Wang T, et al. Stage and cell-specific expression of soluble guanylyl cyclase alpha and beta subunits, cGMP-Dependent protein kinase I-alpha and I-beta, cyclic nucleotide-gated channel subunit-1 in the rat testis. J Androl, 2005, 26(2): 258–263

    Google Scholar 

  47. Shi F, Stewart R L, Pere E, et al. Cell-specific expression and regulation of soluble guanylyl cyclase alpha and beta subunit in the rat ovary. Bio Reprod, 2004, 70: 1552–1561

    Article  Google Scholar 

  48. Shi F, LaPolt P S. Relationship between FoxO1 protein levels and follicular development, atresa, and luteinization. J Endocr. 2003, 179: 195–203

    Article  Google Scholar 

  49. Li X, Jiang Y, Wang Z, et al. Regulation of FoxO1 transcription factor by nitric oxide and cyclic GMP in cultured rat granulosa cells. Zoolog Sci, 2005, 22: 1339–1346

    Article  Google Scholar 

  50. Li X, Xie Z, Shi F. Involvement of forkhead box proteins in apoptosis and oncogenesis. Prog Biochem Biophys (in Chinese), 2005, 32(7): 600–606

    Google Scholar 

  51. Shen Z, Zhao X, Cao Y. Regulation of mouse blastocyst adhesion, outgrowth and secretion of matrix metalloproteinase-2 by cGMP and nitric oxide in vitro. Chin Sci Bull, 2004, 49(11): 1142–1145

    Article  Google Scholar 

  52. Conti M, Andersen C B, Richard F, et al. Role of cyclic nucleotide signaling in oocyte maturation. Mol Cell Endocrinol, 2002, 187(1–2): 153–159

    Article  Google Scholar 

  53. Paruthiyil S, Majdoubi M E, Conti M, et al. Phosphodiesterase expression targeted to gonadotropin-releasing hormone neurons inhibits luteinizing hormone pulses in transgenic rats. Proc Natl Acad Sci USA, 2002, 99(26): 17191–17196

    Article  Google Scholar 

  54. Sadler SE. Type III phosphodiesterase plays a necessary role in the growth-promoting actions of insulin, insulin-like growth factor-I, and Ha p21ras in Xenopus laevis oocytes. Mol Endocrinol, 1991, 5: 1939–1946

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shi FangXiong.

Additional information

Supported by the National Natural Science Foundation of China (Grant No. 30571335) and a Grant-in-Aid for Innovatory Training of Graduated Students in Jiangsu Province, China

About this article

Cite this article

Wang, Z., Shi, F. Phosphodiesterase 4 and compartmentalization of cyclic AMP signaling. CHINESE SCI BULL 52, 34–46 (2007). https://doi.org/10.1007/s11434-007-0025-3

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11434-007-0025-3

Keywords

Navigation